Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Buy Cadila Healthcare; target of Rs 510: Motilal Oswal

Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 510 in its research report dated February 16, 2017.

February 21, 2017 / 03:14 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Motilal Oswal's research report on Cadila Healthcare

Cadila Healthcare (CDH) announced today that its Moraiya facility was re-inspection by the USFDA from 6-15 February 2017. At the end of the inspection, no 483 observations were issued. Notably, this plant is under warning letter status since December 2015.

Outlook

We maintain our Buy rating with a target price of INR 510 @22x FY19E PER (v/s INR 425 @22x 1HFY19E). We increase FY18E/19E EPS by 5%, factoring in faster product approvals and better margins.
For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

first published: Feb 21, 2017 03:14 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347